Pfizer Nixes More Study of Twice-Daily Obesity Pill Treatment That Made Many Patients Nauseous

By Associated Press

Dec 10, 2023

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page